An NCI-designated Comprehensive Cancer Center, affiliated with the University of Pittsburgh School of Medicine
Research
We are pleased to share two exciting announcements for the Genome Stability Program (GSP) at UPMC Hillman Cancer Center. First is the selection of Roddy O’Sullivan, PhD, as the next co-leader of the GSP. In this role, Dr. O’Sullivan will…
Today, the Senior Vice Chancellor for the Health Sciences at the University of Pittsburgh, Anantha Shekhar, MD, PhD, shared the news that Jeremy Rich, MD, MHS, MBA, interim director at UPMC Hillman Cancer Center, has accepted a new role outside…
Please join us in welcoming Natacha De Genna, PhD, to the role of Assistant Center Director for Community Outreach and Engagement (COE) at UPMC Hillman Cancer Center. Dr. De Genna’s role was effective September 1, 2024. She holds appointments as…
This week, Clarivate™ named their list of Highly Cited Researchers for 2024 — an elite group that demonstrates significant and broad influence in their field of research. Each researcher selected has authored multiple Highly Cited Papers™ which rank in the…
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3 cutaneous melanoma, according to the results of a single-arm phase 2 clinical trial led by the…
The results of a recent clinical trial (NCT03743766) published in Cell might pave the way for significant advances in treating advanced melanoma , a serious form of skin cancer. The study, led by University of Pittsburgh and UPMC Hillman Cancer…
We are pleased to share that Jeremy Rich, MD, MHS, MBA, deputy director, UPMC Hillman Cancer Center, has been selected and agreed to serve as interim director, effective Aug. 7, to see us through the transition period with Robert Ferris, MD,…
Please join us in welcoming Michelle Williams, PhD, to UPMC Hillman Cancer Center, effective May 1, 2024. Dr. Williams is Assistant Professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh. Dr. Williams will develop an…
Please join us in welcoming Devanjan “Dev” Sikder, DVM, PhD to UPMC Hillman Cancer Center, effective July 1, 2024. Dr Sikder is Associate Professor in the Department of Medicine, Division of Malignant Hematology/Oncology at the University of Pittsburgh and Director…
Jeffrey Brodsky, PhD, Yuan Chang, MD, and Patrick Moore, MD, MPH, faculty of UPMC Hillman Cancer Center and professors of the University of Pittsburgh, were announced as members to the American Academy of Arts and Sciences. The Academy is a…
